EDITORIAL
Published on 31 Jul 2023
Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?
doi 10.3389/fonc.2023.1247808
- 1,042 views
- 2 citations
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Risk factors in Multiple Myeloma Identified Before and During Treatment: Are We Ready to Personalize Treatment?
Risk factors in Multiple Myeloma Identified Before and During Treatment: Are We Ready to Personalize Treatment?
7,345
Total downloads
23k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 23 Jan 2023
Experts’ consensus on the definition and management of high risk multiple myeloma
doi 10.3389/fonc.2022.1096852
- 7,336 views
- 20 citations
ORIGINAL RESEARCH
Published on 07 Oct 2022
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
doi 10.3389/fonc.2022.938392
- 2,731 views
- 4 citations
REVIEW
Published on 16 Aug 2022
Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy
doi 10.3389/fonc.2022.932852
- 6,979 views
- 8 citations
ORIGINAL RESEARCH
Published on 18 Jul 2022
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials
doi 10.3389/fonc.2022.890376
- 1,893 views
- 2 citations
SYSTEMATIC REVIEW
Published on 18 Feb 2022
Clinical Significance of Circulating Cell-Free DNA Detection in Multiple Myeloma: A Meta-Analysis
doi 10.3389/fonc.2022.852573
- 2,392 views
- 7 citations
Published in
Frontiers in Oncology
- Hematologic Malignancies
Impact
- 23kTopic views
- 15kArticle views
- 7,345Article downloads